TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Rocuronium infusion rate to maintain one twitch of the TOF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response in nasal congestion (>30%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BADE improvement
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: postoperative wound pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oxygenation values (oxygen index and alveolar‐arterial O(2) gradient)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Global assessment by the patient
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Global assessment by the investigator
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Rhinitis and conjunctivitis total scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of severe hypercalcaemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cardiac autonomic modulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Expiratory capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Distance in the 6‐min walk test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of ischemic stroke (IS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: incidence of transitory ischemic attack (TIA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: postoperative neurological complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Improvement of gait parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DASH functional disability scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Quality of life index (QALY differential)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Proportion of patients with HIV RNA of 200 copies/ml or less
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of RV infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak RV shedding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of RV illnesses
Endpoint domain: Adverse events/effects
Primary endpoint: LDL-cholesterol (LDL-C)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: pain score change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of influenza after chemoprophylaxis
Endpoint domain: Adverse events/effects
Primary endpoint: Grade 3 or 4 leukopenia
Endpoint domain: Adverse events/effects
Primary endpoint: Response rates in cancer patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: newly formed bone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adoption of stronger sun safety policies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: feelings of vigor
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: 10-year dialysis-free survival
Endpoint domain: Mortality/survival
Primary endpoint: Vascular reactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Survival free of inappropriate therapy or system revision
Endpoint domain: Mortality/survival
Primary endpoint: micro-tensile bond strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in psoriasis area-and-severity index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Soluble CD23 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Prevention of moderate acute malnutrition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: demineralization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: plaque quantity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tmax delay
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC(0-inf) ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of Vibrio species in shrimp samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Multiple antibiotic-resistant (MAR) index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Identification of virulence genes in Vibrio isolates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Pharmacokinetics of honokiol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive dysfunctions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: intention not to smoke
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: smoking frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rhinological symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sleep function
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Partial Area Under the Curve (pAUC) for prediction of radiographic spinal progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PSA decline >30%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Composite inflammation measure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Cognitive knowledge performance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: safety and effectiveness of dual antiplatelet therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Adiponectin levels increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Response to therapy (defined as a ≥ 50% reduction from the pretreatment score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak plasma concentration (C(max)) of 5-FU
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum hemoglobin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: need for blood transfusions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Successful treatment outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall scores for quality of intubation attempts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: global tenseness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: restlessness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Shear bond strength values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of diarrhoea as a side-effect
Endpoint domain: Adverse events/effects
Primary endpoint: Seroconversion rates against EV71, HBV, and group A meningococcal polysaccharide
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Frequencies of adverse reactions to vaccination regimens
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement in skin microcirculation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Risk of newly diagnosed diabetes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Components of BAI conducted
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Explanation of safe drinking limits
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feedback on patients' alcohol use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: occurrence rate of complications
Endpoint domain: Adverse events/effects
Primary endpoint: relief times of abdominal ache and distention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Skin autofluorescence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: PUVA MPD measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of heartburn episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Median percentage of time at pH<4
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Median number of reflux episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Ease of taking the preparation
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Tolerance of the preparation
Endpoint domain: Adverse events/effects
Primary endpoint: Need to take time off work or change activities
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Acquisition of new STD infection
Endpoint domain: Adverse events/effects
Primary endpoint: total ripening-to-delivery time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cesarean section rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FFS rate at 2 weeks after treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse events developed
Endpoint domain: Adverse events/effects
Primary endpoint: Angiographic luminal late loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: In-scaffold and segment binary restenosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean time to intubate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fiberoptic position of the airway tube
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LFQ score stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CCT change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ECD change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of C3a
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Weight gain on the first postoperative day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Soft-tissue index for edema formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: re-intervention rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Systemic exposure of ciprofloxacin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SF-36 PCS score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: hospitalization cost
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Doses of analgesia required in the first postoperative 24 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: frequency of aggression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvements in social functioning
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Readmission to infirmary or hospital within 2 weeks
Endpoint domain: Adverse events/effects
Primary endpoint: Levels of perilipin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Levels of adropin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Visualization of SLL continuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean scapholunate distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean percent defect resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: crestal resorption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Identification of fetuses with trisomy 21
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Near misses
Endpoint domain: Adverse events/effects
Primary endpoint: Ability to recall Gleason score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Ability to recall number of positive cores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Attendance at the first baseline screening visit
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Time to conduct the informed consent procedure
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Median time until first retreatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Central retinal thickness change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with PLAA above 20%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage weight loss over 6 months
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of mild to moderate adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of moderate to severe neuropsychological adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of moderate or severe skin problems
Endpoint domain: Adverse events/effects
Primary endpoint: excursions in plasma glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: amount of exogenous glucose absorbed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of patient-days with seclusion, restraint, or room observation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Seclusion-restraint time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of violence
Endpoint domain: Adverse events/effects
Primary endpoint: Change in 6MWD
Endpoint domain: Mortality/survival
Primary endpoint: Recovery index 25‐75%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to a TOF ratio of 0.70
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decrease in dietary fat consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Total weighted score for the diagnosis of GORD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: leisure scores
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Extended ADL scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Discharge from hospital alive
Endpoint domain: Mortality/survival
Primary endpoint: Total amount of adrenalin administered
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Acceptability of HPV self-sampling strategy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: procedure-specific skill scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of technical errors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sociometric preference
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: reciprocated friendships
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: positive messages from peers
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: kidney haematomas
Endpoint domain: Adverse events/effects
Primary endpoint: secondary treatments
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of bacterial contamination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Costs of cardiovascular-related inpatient care
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Eating Disorder Examination‐Questionnaire scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of binge eating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Unhealthy eating and exercise behavior
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Composite primary endpoint (all-cause death, myocardial infarction, or stroke)
Endpoint domain: Mortality/survival
Primary endpoint: Cortex perforation incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Physical Activity Frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FeNO values for asthma diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Serum ICAM‐1 levels after six months of treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of bowel movements per week
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Time to successful ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to pass the 'picking up matches' test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ability to sit after extubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urinary TGF‐beta excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Urinary type IV collagen levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: PASI scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: sexual adjustment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: unmet sexual supportive care needs
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: utilisation of sexual aids
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of patients tranquil or asleep at 15 minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients tranquil or asleep at 240 minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for additional drugs over four hours
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: International Index of Erectile Function erectile function domain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of successful penetration attempts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Salivary levels of SLPI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Salivary levels of lysozyme
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical pregnancy rate
Endpoint domain: Life impact
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Live birth rate
Endpoint domain: Life impact
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: on-therapy survival estimate at 18 months
Endpoint domain: Mortality/survival
Primary endpoint: Left ventricular systolic volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: MRI-detected synovitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: MRI-detected osteitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: arousal index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Creatinine reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Esthetic result of crowns
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: infant intestinal microbial diversity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of violence
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Vulnerability to HIV acquisition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean number of Inappropriate Line Crossings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Standard Deviation of Lateral Position of the vehicle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Red blood cell transfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Total premenstrual Daily Symptom Rating Form scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical symptoms improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for rescue antiemetic treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Detection of inguinal canal posterior wall deficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes